A single-photon emission computerized tomography (SPECT) scan creates 3D images of the internal organs and helps the healthcare professionals in analyzing the function of some of internal organs. A SPECT scan uses nuclear medicine and helps in diagnosing and tracking the progression of heart disease, such as blocked coronary arteries. SPECT agents are also available for diagnosing neurological conditions such as Parkinson's.
MARKET DYNAMICS
The SPECT nuclear medicine market is driving due to the growing incidence and prevalence of target health conditions, and increasing number of SPECT procedures. However, short half-life of radiopharmaceuticals may hamper the growth of the global SPECT nuclear medicine market.
MARKET SCOPE
The "SPECT Nuclear Medicine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of SPECT nuclear medicine market with detailed market segmentation by type and application. The SPECT nuclear medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in SPECT nuclear medicine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The SPECT nuclear medicine market is segmented on the basis of type and application. Based on type, the market is segmented as TC-99m, I-123, Tl-201, GA-67, and other SPECT isotopes. On the basis of application, the market is categorized as cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the SPECT nuclear medicine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The SPECT nuclear medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting SPECT nuclear medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the SPECT nuclear medicine market in these regions.
MARKET PLAYERS
The report covers key developments in the SPECT nuclear medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from SPECT nuclear medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for SPECT nuclear medicine in the global market. Below mentioned is the list of few companies engaged in the SPECT nuclear medicine market.
The report also includes the profiles of key players in SPECT nuclear medicine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Cardinal Health
- Curium
- GE Healthcare
- Lantheus Medical Imaging, Inc.
- Bayer AG
- Bracco Imaging S.P.A.
- Eczacibasi-Monrol Nuclear Products
- Nordion, Inc. (A Subsidiary of Sterigenics International)
- Advanced Accelerator Applications (AAA) (A Part of Novartis)
- NTP Radioisotopes Soc, LTD.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.